Correvio Pharma Corp. Stock or Unit Option Plan Expense
Correvio Pharma Corp. reported Stock or Unit Option Plan Expense of $2.42 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2020-04-30
| Period end | Stock or Unit Option Plan Expense 12 month |
|---|---|
| 2019-12-31 | $2.42M 20-F · filed 2020-04-30 |
| 2018-12-31 | $1.68M 20-F · filed 2020-04-30 |
| 2017-12-31 | $2.06M 20-F · filed 2020-04-30 |
| 2016-12-31 | $260.00K 20-F · filed 2018-04-30 |
| 2015-12-31 | $2.21M 20-F · filed 2018-04-30 |
| 2014-12-31 | $1.14M 40-F · filed 2016-03-29 |
| 2013-12-31 | $645.00K 40-F · filed 2015-03-27 |
| 2012-12-31 | $546.00K 40-F/A · filed 2014-04-30 |
| 2011-12-31 | $1.93M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $3.28M 20-F/A · filed 2013-04-18 |